A basic review of Sarcopenia Diagnosis

@#Associated with aging, sarcopenia is characterized by a decline in skeletal muscle mass, muscle strength and physical performance, eventually resulting in reduced physical capability, disability, poor quality of life, mortality in older people and high health care expenditure. The prevalence varies significantly by population characteristics, disease status, diagnostic criteria and measurement tools. It is essential to achieve an accurate diagnosis of sarcopenia for the management plan to be effective. This review briefly discusses the essential steps in diagnosing sarcopenia: Find – Assess – Confirm - Severity.

Pharmacological Treatment of Sarcopenia Tratamento medicamentoso da sarcopenia / Tratamento medicamentoso da sarcopenia Pharmacological Treatment of Sarcopenia

Abstract Sarcopenia has been acquiring a growing importance in the scientific literature and in doctors' offices. As the population ages, it becomes increasingly essential to know, prevent, and treat this clinical condition. The purpose of the present review is to bring up the current evidence on the diagnosis of this pathology, in a practical way, as well as the main current treatment options.

Resumo A sarcopenia vem ganhando cada vez mais importância na literatura científica e nos consultórios médicos. Com o envelhecimento da população, essa condição clínica se torna cada vez mais imprescindível de se conhecer, se prevenir e de se tratar. O objetivo desta revisão é trazer as evidências atuais sobre o diagnóstico dessa patologia, de forma prática, bem como as principais opções atuais de tratamento.

Sarcopenia: Causes, Consequences, Prevention and Treatment

@#The phenomenon of age-related loss of muscle mass and strength was named sarcopenia in 1988 by Rosenberg. Since then, sarcopenia has evolved to include the loss of muscle function in the definition. Sarcopenia has a high prevalence in specific clinical conditions and in the older population and can lead to significant morbidity, poor recovery from adverse events and ultimately, institutionalisation. In spite of the severe health care burden posed, the diagnosis and treatment of sarcopenia have yet to become standard care. Emerging consensus on definition and diagnosis by the international work groups on sarcopenia with tailored population-based cut-offs and growing evidence-based management options will facilitate the meeting of these needs.

Description of sarcopenia frequency and analysis of agreement between the calf circumference and the european consensus for sarcopenia screening in elderly / Descrição da frequência de sarcopenia e análise da concordãncia entre a circunferência da panturrilha e o consenso europeu para o rastreio de sarcopenia em idosos / Descripción sarcopenia frecuencia y análisis del acurdo entre el becerro circunferencia nivel y el consenso europeo para la sarcopenia cribado en el anciano

This study aimed to describe the frequency of sarcopenia and verify the agreement between instruments for diagnosis. This a cross-sectional study, where we used the algorithm proposed by the European Consensus Sarcopenia in Older People (EWGSOP), calf circumference (CC), muscle mass and body mass index. 167 elderly were evaluated with a mean age of 68.03 ± 6.12 years. The elderly frequency screened by EWGSOP sarcopenia and CC was as follows: 40 (24.0%) 27(16.2%) and 15 (9.0%). A low degree of agreement between CC and the EWGSOP (Ò¡ = 0.192) was found. However, these instruments due to the low financial cost and easy applicability are important auxiliary tools for the screening of sarcopenia in elderly.

Este estudo teve o objetivo descrever a frequência de sarcopenia e verificar a concordância entre instrumentos para o seu diagnóstico. Trata-se de estudo transversal onde foram utilizados o algoritmo proposto pelo Consenso Europeu de Sarcopenia em idosos (EWGSOP), circunferência da panturrilha (CP), massa muscular e índice de massa muscular. 167 idosos foram avaliados com idade média de 68.03±6.12 anos. A frequência de idosos rastreados com sarcopenia pelo EWGSOP e CP foi a seguinte: 27(16.2%) e 15 (9.0%). Foi verificado um fraco grau de concordância entre a CP e o EWGSOP (Ò¡ = 0.192). Contudo, esses instrumentos, devido ao baixo custo financeiro e fácil aplicabilidade são ferramentas auxiliares importantes para o rastreio de sarcopenia em idosos.

Este estudio tuvo como objetivo describir la frecuencia de la sarcopenia y verifique el acuerdo entre los instrumentos para el diagnóstico. Este estudio transversal donde se utilizó el algoritmo propuesto por el Consenso Europeo Sarcopenia en Anciano (EWGSOP), circunferencia de la pantorrilla (CP), la masa muscular y el índice de masa corporal. 167 ancianos fueron evaluados con una edad media de 68,03 ± 6,12 años. Las personas mayores a menudo diagnosticada por EWGSOP sarcopenia y CP fue el siguiente: 27 (16.2%) y 15 (9.0%). Se encontró un bajo grado de correlación entre la CP y el EWGSOP (Ò¡ = 0.192). Sin embargo, estos instrumentos debido al bajo costo financiero y de fácil aplicabilidad son ayudas importantes para la detección y el diagnóstico de la sarcopenia en los ancianos.